Success Metrics

Clinical Success Rate
93.8%

Based on 15 completed trials

Completion Rate
94%(15/16)
Active Trials
0(0%)
Results Posted
7%(1 trials)
Terminated
1(6%)

Phase Distribution

Ph phase_2
2
11%
Ph not_applicable
13
72%
Ph phase_1
2
11%

Phase Distribution

2

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution17 total trials
Phase 1Safety & dosage
2(11.8%)
Phase 2Efficacy & side effects
2(11.8%)
N/ANon-phased studies
13(76.5%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

93.8%

15 of 16 finished

Non-Completion Rate

6.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

18

all time

Status Distribution
Completed(15)
Terminated(1)
Other(2)

Detailed Status

Completed15
unknown2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
18
Active
0
Success Rate
93.8%
Most Advanced
Phase 2

Trials by Phase

Phase 12 (11.8%)
Phase 22 (11.8%)
N/A13 (76.5%)

Trials by Status

completed1583%
terminated16%
unknown211%

Recent Activity

0 active trials
Showing 5 of 18
completednot_applicable

Tertiary Prevention of Child Sexual Abuse

NCT06126926
completedphase_1

A Second Psilocybin Group Therapy for the Treatment of Cancer-Related Anxiety in Partial Responders With Metastatic Cancer

NCT06644170
completednot_applicable

ACT-group for Stroke Survivors (Pilot Study)

NCT06282029
completednot_applicable

EEG-Triggered rTMS and Group Therapy for Adolescents With Depression and Self-Harm

NCT07047534
completedphase_1

Group MDMA-therapy for Veterans With PTSD

NCT05961527
View all 18 trials

Clinical Trials (18)

Showing 18 of 18 trials
NCT06126926Not Applicable

Tertiary Prevention of Child Sexual Abuse

Completed
NCT06644170Phase 1

A Second Psilocybin Group Therapy for the Treatment of Cancer-Related Anxiety in Partial Responders With Metastatic Cancer

Completed
NCT06282029Not Applicable

ACT-group for Stroke Survivors (Pilot Study)

Completed
NCT07047534Not Applicable

EEG-Triggered rTMS and Group Therapy for Adolescents With Depression and Self-Harm

Completed
NCT05961527Phase 1

Group MDMA-therapy for Veterans With PTSD

Completed
NCT00297479Not Applicable

Group Therapy for Nicotine Dependence: Mindfulness and Smoking

Completed
NCT01626586Not Applicable

Diabetes Adolescent and Family Group Therapy

Completed
NCT04127201Not Applicable

En_Línea. An Online Treatment to Change Lifestyle in Overweight and Obesity

Unknown
NCT03227744Not Applicable

A Pilot Study of Prostate Cancer-specific Anxiety in Active Surveillance

Terminated
NCT00131534

The Trauma Recovery and Resiliency Research Project

Completed
NCT02794051Not Applicable

Transdiagnostic Group Intervention for Children With Behavior Problems

Completed
NCT00877994Not Applicable

Nurture: A Program for Mothers With Histories of Disordered Eating

Completed
NCT01823250Phase 2

Culturally Informed Family Based Treatment of Adolescents: A Randomized Trial

Completed
NCT00622271Not Applicable

Intervention Groups for Adolescents With Type 1 Diabetes Mellitus

Completed
NCT00801970Not Applicable

Fear of Childbirth (Tokophobia) - Etiology, Essence and Clinical Implications

Unknown
NCT00527683Phase 2

Double Blind Study of Vigabatrin for the Treatment of Cocaine Dependence

Completed
NCT00229320Not Applicable

Short Term Group Therapy for OCD

Completed
NCT00229281Not Applicable

Short Term Group Therapy for Anxiety Disorder

Completed

All 18 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
18